Resolute Wealth Strategies LLC Sells 172 Shares of The Procter & Gamble Company (NYSE:PG)

Resolute Wealth Strategies LLC lowered its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 4.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,820 shares of the company’s stock after selling 172 shares during the quarter. Resolute Wealth Strategies LLC’s holdings in Procter & Gamble were worth $560,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of PG. Moreno Evelyn V grew its stake in shares of Procter & Gamble by 1.9% during the 3rd quarter. Moreno Evelyn V now owns 54,345 shares of the company’s stock worth $7,927,000 after acquiring an additional 1,037 shares in the last quarter. Nixon Peabody Trust Co. grew its position in Procter & Gamble by 0.7% in the third quarter. Nixon Peabody Trust Co. now owns 13,886 shares of the company’s stock valued at $2,025,000 after purchasing an additional 100 shares in the last quarter. Cohen Lawrence B increased its stake in Procter & Gamble by 5.9% in the 3rd quarter. Cohen Lawrence B now owns 20,384 shares of the company’s stock valued at $2,973,000 after buying an additional 1,135 shares during the last quarter. Busey Trust CO lifted its position in Procter & Gamble by 0.6% during the 3rd quarter. Busey Trust CO now owns 194,111 shares of the company’s stock worth $28,313,000 after buying an additional 1,233 shares in the last quarter. Finally, RMR Wealth Builders grew its holdings in shares of Procter & Gamble by 51.6% in the 3rd quarter. RMR Wealth Builders now owns 8,727 shares of the company’s stock valued at $1,273,000 after acquiring an additional 2,971 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on PG. Argus increased their price target on Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Thursday, April 25th. Jefferies Financial Group raised their target price on shares of Procter & Gamble from $175.00 to $182.00 and gave the company a “buy” rating in a research note on Monday, April 22nd. Royal Bank of Canada upped their price target on shares of Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 24th. JPMorgan Chase & Co. decreased their price objective on shares of Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating for the company in a research report on Thursday, January 18th. Finally, The Goldman Sachs Group assumed coverage on shares of Procter & Gamble in a report on Friday, March 1st. They issued a “neutral” rating and a $168.00 target price on the stock. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $169.76.

View Our Latest Analysis on Procter & Gamble

Procter & Gamble Price Performance

Procter & Gamble stock traded up $0.62 during trading hours on Friday, reaching $164.46. 5,581,692 shares of the stock were exchanged, compared to its average volume of 6,941,715. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The company has a market cap of $388.15 billion, a P/E ratio of 26.87, a price-to-earnings-growth ratio of 3.34 and a beta of 0.43. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $164.71. The stock has a 50 day moving average of $160.01 and a two-hundred day moving average of $154.17.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. During the same quarter in the prior year, the firm posted $1.37 earnings per share. The firm’s revenue was up .6% compared to the same quarter last year. Equities analysts expect that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.45%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Insiders Place Their Bets

In related news, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the transaction, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Procter & Gamble news, insider Susan Street Whaley sold 3,865 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $160.60, for a total transaction of $620,719.00. Following the completion of the sale, the insider now directly owns 11,886 shares in the company, valued at approximately $1,908,891.60. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the transaction, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The disclosure for this sale can be found here. In the last three months, insiders have sold 86,865 shares of company stock valued at $14,059,180. 0.17% of the stock is currently owned by company insiders.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.